Home > Boards > US Listed > Biotechs > Cyclo Therapeutics (CYTH)

QualityStocks just came out with a nice report

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
tradrdad45 Member Profile
 
Followed By 1
Posts 246
Boards Moderated 0
Alias Born 06/10/08
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/15/2021 3:40:03 PM
Cyclo Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTech Summit Business Wire - 9/15/2021 8:05:00 AM
Cyclo Therapeutics to Present at H.C. Wainwright 23rd Annual Global Investment Conference Business Wire - 9/8/2021 8:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/1/2021 5:08:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/31/2021 2:42:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/30/2021 7:51:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/30/2021 7:05:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/30/2021 7:05:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/30/2021 7:05:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/30/2021 7:04:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/30/2021 7:03:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/30/2021 7:03:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/30/2021 7:03:12 PM
Cyclo Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results Business Wire - 8/17/2021 8:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/16/2021 4:52:43 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/16/2021 4:36:49 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/16/2021 4:03:37 PM
Cyclo Therapeutics reports new positive data from early-stage rare genetic disorder study Seeking Alpha - 7/30/2021 8:37:03 AM
Cyclo Therapeutics Announces New Positive Safety and Efficacy Data from Ongoing Phase 1 Open-Label Extension Study of Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1 Business Wire - 7/30/2021 8:05:00 AM
Cyclo Therapeutics Commences Commercial-Scale Manufacturing for Trappsol® Cyclo™ Business Wire - 7/27/2021 8:05:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2021 4:04:09 PM
Cyclo Therapeutics to Present at the 2021 NPC Patient and Family Conference Hosted by the Australian NPC Disease Foundation Business Wire - 6/21/2021 8:05:00 AM
Cyclo Therapeutics soars 10% on launch of Phase 3 Trappsol Cyclo study in rare genetic disorder Seeking Alpha - 6/17/2021 8:28:24 AM
Cyclo Therapeutics Commences Patient Enrollment in TransportNPC, a Pivotal Phase 3 Study Evaluating Trappsol® Cyclo™ in Ni... Business Wire - 6/17/2021 8:05:00 AM
Cyclo Therapeutics Announces Launch of New Website Business Wire - 6/15/2021 8:05:00 AM
tradrdad45   Thursday, 10/30/08 04:51:43 PM
Re: None
Post # of 22 
QualityStocks just came out with a nice report on CleanTech BioFuels:

CleanTech BioFuels, Inc. (CLTH) is focused on developing ground-breaking technologies to convert cellulosic material found in municipal solid waste (MSW) into ethanol. Out of the 250+ million tons of garbage disposed of each year in America, only 32% is recovered, 14% is burned at combustion facilities and the remaining 54% is tossed in landfills. However, using CleanTech’s technology, this unusable waste is a source of energy rather than a disposal problem.

The company holds exclusive licenses to a collection of technologies that offer substantial advantages in converting MSW into viable energy. CleanTech is also developing an exclusive license to produce ethanol from municipal garbage by utilizing a dilute acid hydrolysis process that transforms cellulosic feedstock into fermentable sugars. Together, these technologies will allow CleanTech to produce cellulosic ethanol from municipal garbage at low costs.

Because the company has such a unique method of solving disposal issues while also addressing our dependence on foreign oils, it has been presented with opportunities to joint venture, license or acquire other related technologies that can also be used to convert municipal garbage into energy. CleanTech anticipates developing other complementary technologies to convert even greater amounts of the municipal waste stream into clean fuels.

The demand for the production of ethanol has grown to incredible levels with the recent volatility in oil prices and recently enacted legislation requiring a production rate of 36 billion gallons of ethanol per year by 2022. Ethanol from agricultural products like corn and sugar cane isn’t expected to be able to meet this mandate, creating an even stronger demand for advanced biofuels such as cellulosic ethanol.

http://clth.qualitystocks.net/


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences